Filing Imminent As Mycovia’s Antifungal Prevents Recurrent Vulvovaginal Candidiasis

Private Company Is Preparing For Commercialization, Talking To Partners

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.